This inventor holds 2 USPTO granted patents. Top assignees: Northeastern University, University of Florida Research Foundation Inc.. Active years: 2018-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 687 
1 out of 3,056 
Years Active: 2018-2022
Title: Abhijit Raghunath Kulkarni: Innovator in Neurological Treatments
Introduction
Abhijit Raghunath Kulkarni is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of neuroscience through his innovative patents. With a total of 2 patents, Kulkarni's work focuses on developing compounds that address various neurological and inflammatory conditions.
Latest Patents
Kulkarni's latest patents include "Ligands for alpha-7 nicotinic acetylcholine receptors and methods of treating neurological and inflammatory conditions." This patent describes compounds that bind to an allosteric site on the mammalian alpha-7 nicotinic acetylcholine receptor (alpha-7 nAChR). These compounds act as positive allosteric modulators and are useful in diagnosing, preventing, or treating disorders related to cognition, learning, memory, neurodegeneration, drug addiction, inflammation, chronic pain, and neuropathic pain. Additionally, these compounds can enhance memory and learning in normal individuals. Another significant patent is for "Allosteric modulators of the cannabinoid 1 receptor." This technology relates to compounds and compositions that may be used in the treatment or prophylaxis of addiction, metabolic syndrome, obesity, and other CB1 receptor-mediated disorders.
Career Highlights
Kulkarni has worked with esteemed institutions such as Northeastern University and the University of Florida Research Foundation Inc. His research has contributed to advancements in understanding and treating complex neurological conditions.
Collaborations
Some of his notable coworkers include Ganeshsingh Arjunsingh Thakur and Pushkar Mukund Kulkarni. Their collaborative efforts have furthered the impact of Kulkarni's research in the scientific community.
Conclusion
Abhijit Raghunath Kulkarni is a distinguished inventor whose work in developing innovative treatments for neurological and inflammatory conditions has the potential to improve countless lives. His contributions to science and medicine are commendable and reflect his dedication to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile